EN
HI
Gujarat Terce Laboratories Share price
GUJTERC
38
1.64 (4.51%)Last updated on 19 Aug, 2026 | 16:01 IST
Gujarat Terce Laboratories share price chart
Gujarat Terce Laboratories Share Key Metrics
Volume
917.00
Market Cap
28.31 CR
LTQ@LTP
1@38.00
ATP
38.46
Var Margin
31.03 %
Circuit Range
29.09-43.63
Delivery %
54.19 %
Value
35267.82
ASM/GSM
No
Market Lot
1
Summary
GUJTERC stock price is ₹38 as of 19 Aug, 2026. The stock intraday movement has stayed between ₹36.01 and ₹39.95, while Gujarat Terce Laboratories share price 52 week high low is ₹29.00 & ₹59.78.
In terms of trading activity, GUJTERC share price has recorded a volume of 917 shares. The Gujarat Terce Laboratories has a market cap of ₹7791300. The stock’s Average Traded Price (ATP) stands at ₹38.46, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹38.00.
The Gujarat Terce Laboratories upper circuit limit is ₹43.63 & The Gujarat Terce Laboratories lower circuit limit is ₹29.09, with a Value of ₹35267.82. The Delivery Percentage for the day is 54.19%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Gujarat Terce Laboratories Resistance and Support
Pivot 37.44
Resistance
First Resistance
39.48
Second Resistance
42.59
Third Resistance
44.63
Support
First Support
34.33
Second Support
32.29
Third Support
29.18
Gujarat Terce Laboratories Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
40.03%
Mutual Fund
0%
Insurance
0%
Foreign Institutional Investors
0%
Domestic Institutional Investors
0%
Retail
59.97%
Others
0%
Total Promoters
MAR '26
40.03%
JUN '26
40.03%
Gujarat Terce Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-07 | Quarterly Results |
| 2026-05-29 | Audited Results & A.G.M. |
| 2026-05-27 | Audited Results & A.G.M. |
| 2026-02-04 | Quarterly Results |
| 2025-11-08 | Quarterly Results |
| 2025-08-11 | Quarterly Results |
| 2025-07-17 | Others |
| 2025-05-26 | Audited Results & Others |
| 2025-02-04 | Quarterly Results |
| 2024-10-28 | Quarterly Results & A.G.M. |
| 2024-08-09 | Quarterly Results & A.G.M. |
Gujarat Terce Laboratories News
Gujarat Terce Laboratories Ltd - 524314 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 7 August 2026
Gujarat Terce Laboratories board approved Q1 FY27 standalone financial results, reporting total revenue of ₹9.48 crore and a net loss of ₹0.18 crore. The results were subjected to a limited review by statutory auditor Shah Doshi Patel & Associates LLP.
Aug 07 2026 16:51:51
Gujarat Terce Laboratories Ltd - 524314 - Board Meeting Intimation for Approving The Unaudited Standalone Financial Results Of The Company For The First Quarter Ended On 30 June 2026
Gujarat Terce Laboratories board is scheduled to meet on August 7, 2026, to review and approve the financial results for the first quarter ended June 30, 2026. This meeting is a routine quarterly update for investors.
Aug 01 2026 16:09:04
Gujarat Terce Laboratories Management
| Name | Position |
|---|---|
| Viplav S Khamar | Non Executive Independent Director |
| SP Sharma | Non Executive Independent Director |
Gujarat Terce Laboratories Similar Stocks
Panjon Ltd.
18.73
0.00 (0.00%)
Bandaram Pharma Packtech Ltd.
17.99
-0.01 (0.06%)
Zenith Health Care Ltd.
3.10
0.01 (0.32%)
Chennai Meenakshi Multispeciality Hospital Ltd.
36.25
-1.10 (2.95%)
Deccan Health Care Ltd.
13.20
0.25 (1.93%)
Tejnaksh Healthcare Ltd.
13.10
-0.06 (0.46%)
Gujarat Inject (Kerala) Ltd.
12.00
-0.63 (4.99%)
Gujarat Terce Laboratories FAQs
The Buying Price of Gujarat Terce Laboratories share is 38 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Gujarat Terce Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Gujarat Terce Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Gujarat Terce Laboratories shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Gujarat Terce Laboratories shares is 0. Useful to assess the stock's value relative to its book value.
To assess Gujarat Terce Laboratories’s valuation compare Sector P/E, P/B which are 64.9 & 3.32 with sector averages, along with growth rates and financial metrics.
The Market Cap of Gujarat Terce Laboratories is 28.31 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Gujarat Terce Laboratories share price is 59.78 & 29.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Gujarat Terce Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Invest in GUJTERC
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC